Diels J - Search Results

1

Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison.

Van Sanden S, Baculea S, Diels J, Cote S. Van Sanden S, et al. Among authors: diels j. Adv Ther. 2017 Jul;34(7):1650-1661. doi: 10.1007/s12325-017-0564-1. Epub 2017 Jun 1. Adv Ther. 2017. PMID: 28573505 Free PMC article.

2

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy.

Backx M, Lewszuk A, White JR, Cole J, Sreedharan A, van Sanden S, Diels J, Lawson A, Neal KR, Wiselka MJ, Ito T, Irving WL. Backx M, et al. Among authors: diels j. J Viral Hepat. 2014 Mar;21(3):208-15. doi: 10.1111/jvh.12132. Epub 2013 Aug 1. J Viral Hepat. 2014. PMID: 24438682

3

Converging or Crossing Curves: Untie the Gordian Knot or Cut it? Appropriate Statistics for Non-Proportional Hazards in Decitabine DACO-016 Study (AML).

Tomeczkowski J, Lange A, Güntert A, Thilakarathne P, Diels J, Xiu L, De Porre P, Tapprich C. Tomeczkowski J, et al. Among authors: diels j. Adv Ther. 2015 Sep;32(9):854-62. doi: 10.1007/s12325-015-0238-9. Epub 2015 Sep 14. Adv Ther. 2015. PMID: 26369324 Free PMC article. Clinical Trial.

4

Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden.

Thilakarathne P, Diels J, van Sanden S, Liwing J, Van Agthoven M, Chirita O, Nahi H. Thilakarathne P, et al. Among authors: diels j. Value Health. 2014 Nov;17(7):A545-6. doi: 10.1016/j.jval.2014.08.1767. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201764 Free article. No abstract available.

5

Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple Myeloma.

Thilakarathne P, Palumbo A, Diels J, Delforge M, van Sanden S, Mateos MV, Chirita O, Dimopoulos MA, van de Velde H, San Miguel JF. Thilakarathne P, et al. Among authors: diels j. Value Health. 2014 Nov;17(7):A546. doi: 10.1016/j.jval.2014.08.1770. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201769 Free article. No abstract available.

6

Bortezomib Re-treatment in Patients with Multiple Myeloma (MM). A Real World Medical Practice Experience from a Swedish National Registry.

Thilakarathne P, Diels J, van Sanden S, Liwing J, Chirita O, Van Agthoven M, Nahi H. Thilakarathne P, et al. Among authors: diels j. Value Health. 2014 Nov;17(7):A617. doi: 10.1016/j.jval.2014.08.2181. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202162 Free article. No abstract available.

7

Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia.

Sorensen S, Wildgust M, Sengupta N, Trambitas C, Diels J, van Sanden S, Xu Y, Dorman E. Sorensen S, et al. Among authors: diels j. Clin Ther. 2017 Jan;39(1):178-189.e5. doi: 10.1016/j.clinthera.2016.12.001. Epub 2017 Jan 3. Clin Ther. 2017. PMID: 28062113 Review.

8

Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison.

Usmani SZ, Diels J, Ito T, Mehra M, Khan I, Lam A. Usmani SZ, et al. Among authors: diels j. Am J Hematol. 2017 Aug;92(8):E146-E152. doi: 10.1002/ajh.24781. Epub 2017 Jun 5. Am J Hematol. 2017. PMID: 28474745 Free PMC article.

9

Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.

Hansson L, Asklid A, Diels J, Eketorp-Sylvan S, Repits J, Søltoft F, Jäger U, Österborg A. Hansson L, et al. Among authors: diels j. Ann Hematol. 2017 Oct;96(10):1681-1691. doi: 10.1007/s00277-017-3061-3. Epub 2017 Jul 31. Ann Hematol. 2017. PMID: 28762081 Free PMC article. Clinical Trial.

10

PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies.

Garside J, Healy N, Besson H, Hermans R, MacDougall F, Lestelle D, Diels J, Iraqi W. Garside J, et al. Among authors: diels j. J Comp Eff Res. 2018 Jan;7(1):29-38. doi: 10.2217/cer-2017-0046. Epub 2017 Aug 2. J Comp Eff Res. 2018. PMID: 28766976 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters